Invention Application
- Patent Title: Novel Tumor Biomarket
- Patent Title (中): 新型肿瘤生物市场
-
Application No.: US12880265Application Date: 2010-09-13
-
Publication No.: US20120064078A1Publication Date: 2012-03-15
- Inventor: Yongzhang LUO , Xiaomin SONG , Xiaofeng WANG , Wei ZHUO , Guodong CHANG , Yan FU
- Applicant: Yongzhang LUO , Xiaomin SONG , Xiaofeng WANG , Wei ZHUO , Guodong CHANG , Yan FU
- Applicant Address: CN Beijing CN Beijing
- Assignee: PROTGEN LTD.,TSINGHUA UNIVERSITY
- Current Assignee: PROTGEN LTD.,TSINGHUA UNIVERSITY
- Current Assignee Address: CN Beijing CN Beijing
- Main IPC: A61K39/395
- IPC: A61K39/395 ; G01N33/68 ; A61P35/02 ; C12N5/09 ; A61P35/00 ; A61P35/04 ; C07K14/47 ; G01N33/566
Abstract:
The present invention relates to the diagnosis and treatment of cancer, and specifically to a method of diagnosing the presence or metastasis of cancer by detecting plasma Hsp90α having the amino acid sequence of SEQ ID No.1 as a tumor marker. In addition, the present invention also relates to a method for the treatment of cancer and metastasis.
Public/Granted literature
- US08389684B2 Tumor biomarker Public/Granted day:2013-03-05
Information query
